CYSTATIN C BINDS AMYLOID β AND INHIBITS ITS OLIGOMERIZATION, FIBRIL FORMATION, AND DEPOSITION IN ALZHEIMER'S DISEASE MOUSE MODELS

被引：0
|
作者：
Levy, Efrat [1 ,2 ]
机构：
[1] NYU, Sch Med, Dept Psychiat, Nathan S Kline Inst, Orangeburg, NY USA
[2] NYU, Sch Med, Dept Pharmacol, Nathan S Kline Inst, Orangeburg, NY USA
来源：
NEUROPEPTIDES | 2009年 / 43卷 / 02期
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页码：149 / 150
页数：2
相关论文
共 50 条
  • [21] Maple syrup extract inhibits the beta-amyloid and tau oligomerization of Alzheimer's disease
    Weaver, Donald
    Hawco, Cassandra
    Wang, Yan-Fei
    Taylor, Marcia
    ABSTRACTS OF PAPERS OF THE AMERICAN CHEMICAL SOCIETY, 2016, 251
  • [22] Prevention of domain swapping inhibits dimerization and amyloid fibril formation of cystatin C -: Use of engineered disulfide bridges, antibodies, and carboxymethylpapain to stabilize the monomeric form of cystatin C
    Nilsson, M
    Wang, X
    Rodziewicz-Motowidlo, S
    Janowski, R
    Lindström, V
    Önnerfjord, P
    Westermark, G
    Grzonka, Z
    Jaskolski, M
    Grubb, A
    JOURNAL OF BIOLOGICAL CHEMISTRY, 2004, 279 (23) : 24236 - 24245
  • [23] Atomic force microscopic imaging of seeded fibril formation and fibril branching by the Alzheimer's disease amyloid-β protein
    Harper, JD
    Lieber, CM
    Lansbury, PT
    CHEMISTRY & BIOLOGY, 1997, 4 (12): : 951 - 959
  • [24] Surface plasmon resonance for the analysis of β-amyloid interactions and fibril formation in alzheimer’s disease research
    Marie -Isabel Aguilar
    David H Small
    Neurotoxicity Research, 2005, 7 : 17 - 27
  • [25] Amyloid β-Protein Assembly and Alzheimer's Disease: Dodecamers of Aβ42, but Not of Aβ40, Seed Fibril Formation
    Economou, Nicholas J.
    Giammona, Maxwell J.
    Do, Thanh D.
    Zheng, Xueyun
    Teplow, David B.
    Buratto, Steven K.
    Bowers, Michael T.
    JOURNAL OF THE AMERICAN CHEMICAL SOCIETY, 2016, 138 (06) : 1772 - 1775
  • [26] Inhibitory Effect of β-Casein on the Amyloid Fibril Formation of Aβ1–40 Associated with Alzheimer’s Disease
    Arezou Ghahghaei
    Sima Shahraki
    International Journal of Peptide Research and Therapeutics, 2016, 22 : 23 - 29
  • [27] Alzheimer's Disease: Insights into Amyloid Fibril Formation from Lattice Monte Carlo Simulations
    Thanh-Thuy Tran
    Nguyen, Phuong H.
    Derreumaux, Philippe
    BIOPHYSICAL JOURNAL, 2016, 110 (03) : 219A - 219A
  • [28] Olfactory deprivation promotes amyloid β deposition in a mouse model of Alzheimer's disease
    Zhao, Xirun
    Zhou, Qing
    Zhang, Huan
    Ono, Munenori
    Furuyama, Takafumi
    Yamamoto, Ryo
    Ishikura, Tomoko
    Kumai, Masami
    Nakamura, Yukari
    Shiga, Hideaki
    Miwa, Takaki
    Kato, Nobuo
    BRAIN RESEARCH, 2025, 1851
  • [29] Contribution of amyloid deposition from oligodendrocytes in a mouse model of Alzheimer's disease
    Ishii, Akihiro
    Pathoulas, Joseph A.
    Omar, Omar MoustafaFathy
    Ge, Yingying
    Yao, Annie Y.
    Pantalena, Tressa
    Singh, Neeraj
    Zhou, John
    He, Wanxia
    Murphy, Patrick
    Yan, Riqiang
    Hu, Xiangyou
    MOLECULAR NEURODEGENERATION, 2024, 19 (01)
  • [30] Expression of Genes Associated with Cellular Senescence in Alzheimer's Disease and Transgenic Mouse Models with Amyloid Deposition or Tauopathy
    Gordon, M. N.
    Beck, J. S.
    Kanaan, N. M.
    Kamath, S.
    Nash, K.
    Ginsberg, S. D.
    Counts, S. E.
    CELL TRANSPLANTATION, 2021, 30 : 6 - 7
12345